This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:MDS, Danaher get second request on MDS Analytical sale 2009-11-03 09:13 ET - News Release Mr. Peter Dans reports MDS INC. AND DANAHER CORPORATION RECEIVE SECOND REQUEST FOR INFORMATION FROM U.S. FEDERAL TRADE COMMISSION FOR MDS ANALYTICAL TECHNOLOGIES SALE MDS Inc. and Danaher Corp. have each received a second request for information from the Federal Trade Commission (FTC) regarding the sale of MDS Analytical Technologies.
The second request relates to a global market segment that MDS and Danaher estimate generates less than $50-million in annual revenues for all sellers combined.
The information request was issued under notification requirements of the Hart Scott Rodino Antitrust Improvements Act of 1976, as amended (HSR Act). The effect of the second request is to extend the waiting period imposed by the HSR Act for a period of 30 calendar days from the date of the parties' substantial compliance with the request, unless the waiting period is earlier terminated. The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |
Top
Print this Page